Nifedipine XL 30mg
Showing 26 - 50 of 779
Aortic Stenosis Trial in Camperdown, Brisbane, Clayton (ACURATE Prime XL Transfemoral Aortic Valve System)
Active, not recruiting
- Aortic Stenosis
- ACURATE Prime XL Transfemoral Aortic Valve System
-
Camperdown, New South Wales, Australia
- +2 more
Oct 25, 2022
Solid Tumor, Lymphoma, B-Cell Trial in Guangzhou (LP-118 tablet)
Recruiting
- Solid Tumor
- Lymphoma, B-Cell
- LP-118 tablet
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
Sep 15, 2021
Alzheimer Trial in Changsha (AD16 30mg?40mg, AD16 Placebo 30mg?40mg)
Completed
- Alzheimer Disease
- AD16 30mg、40mg
- AD16 Placebo 30mg、40mg
-
Changsha, ChinaThe Central South University Xiang Ya Hospital
Mar 28, 2023
Laryngeal Cancer Trial in Ann Arbor (AT-101, Docetaxel, Cisplatin)
Completed
- Laryngeal Cancer
- AT-101
- +3 more
-
Ann Arbor, MichiganUniversity of Michigan Comprehensive Cancer Center
Dec 17, 2021
DermaClose DUKE Fasciotomy and Wound Study
Recruiting
- Wound of Skin
- DermaClose Continuous External Tissue Expander Device
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Dec 29, 2022
Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics
Recruiting
- Systolic Hypertension
- +4 more
- Labetalol
- +2 more
-
Huntington, West VirginiaMaternal Hypertension Center at Cabell Huntington Hospital
Sep 6, 2022
Actinic Keratosis, Keratosis, Actinic, Keratosis Trial in United States (BF-200 ALA and red light LED lamp)
Recruiting
- Actinic Keratosis
- +2 more
- BF-200 ALA and red light LED lamp
-
Phoenix, Arizona
- +8 more
Jan 12, 2023
Preterm Labor Trial in Dallas (Nifedipine, Placebo, Usual care)
Erosive Reflux Disease Trial in Iksan (Tegoprazan 50mg QD, Lansoprazole 30mg QD)
Completed
- Erosive Reflux Disease
- Tegoprazan 50mg QD
- Lansoprazole 30mg QD
-
Iksan, Muwang-ro 895, Korea, Republic ofWonkwang University Hospital
Jul 28, 2022
Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral) Trial in Shanghai (Sodium)
Completed
- Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
- Sodium
-
Shanghai, Shanghai, ChinaYiran Jiang
Dec 7, 2022
Preterm Labor Trial in Houston (Nifedipine, Indomethacin)
Terminated
- Preterm Labor
-
Houston, TexasMemorial Hermann Hospital Texas Medical Center
Oct 25, 2021
H. Pylori Infection Trial ((A) T-V14, (B) T-V7, (C) D-V14)
Not yet recruiting
- H. Pylori Infection
- (A) T-V14
- +7 more
- (no location specified)
Jan 14, 2021
High Grade Serous Carcinoma, Triple Negative Breast Cancer, Ovarian Cancer Trial (Olaparib tablet, Navitoclax)
Recruiting
- High Grade Serous Carcinoma
- +2 more
- Olaparib tablet
- Navitoclax
-
Toronto, Ontario, Canada
- +2 more
Nov 28, 2022
End Stage Renal Disease Trial in Los Angeles (Tacrolimus Extended-Release Oral Capsule)
Completed
- End Stage Renal Disease
- Tacrolimus Extended-Release Oral Capsule
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Jan 7, 2022
Diabetes Trial in France (Eversense XL CGM System, Usual SMBG or FGM device used by participants)
Completed
- Diabetes Mellitus
- Eversense XL CGM System
- Usual SMBG or FGM device used by participants
-
Amiens, France
- +19 more
Aug 13, 2021
Bipolar I Disorder Trial in Vancouver (Escitalopram, Wellbutrin XL)
Completed
- Bipolar I Disorder
- Escitalopram
- Wellbutrin XL
-
Vancouver, British Columbia, CanadaUniversity of British Columbia
Jul 9, 2021
Type2 Diabetes Trial in Seoul (Metformin=1000mg, Pioglitazone 15mg, Pioglitazone 30 mg)
Active, not recruiting
- Type2 Diabetes
- Metformin≥1000mg
- +5 more
-
Seoul, Korea, Republic ofAsan Medical Center
Apr 12, 2022
Primary Aldosteronism, Hypertension Trial (Finerenone, Spironolactone)
Not yet recruiting
- Primary Aldosteronism
- Hypertension
- (no location specified)
Apr 3, 2023
Third Molar Extraction Trial in São Paulo (FDC of etoricoxib + cyclobenzaprine + etoricoxib , etoricoxib 90 mg (Arcoxia®) +FDC ,
Not yet recruiting
- Third Molar Extraction
- FDC of etoricoxib + cyclobenzaprine + etoricoxib placebo
- +2 more
-
São Paulo, SP, BrazilEurofarma Laboratorios S.A
Jan 11, 2023
Psoriasis Trial in Lahore (Apremilast 30mg)
Completed
- Psoriasis
- Apremilast 30mg
-
Lahore, Punjab, PakistanGhurki Hospital
Sep 5, 2023
Medullary Thyroid Cancer Trial in Worldwide (Cabozantinib (XL184) 140 mg, Cabozantinib (XL184) 60 mg, Placebo tablet)
Active, not recruiting
- Medullary Thyroid Cancer
- Cabozantinib (XL184) 140 mg
- +3 more
-
St. Leonards, New South Wales, Australia
- +49 more
Jan 23, 2023
Small Cell Lung Cancer and Other Solid Tumors Trial in Guangzhou (APG-1252)
Terminated
- Small Cell Lung Cancer and Other Solid Tumors
-
Guangzhou, Guangdong, ChinaGuangdong General Hospital
Aug 24, 2021
Preterm Premature Rupture of Membrane Trial in Paris (Nifedipine, Placebo of Nifedipine)
Recruiting
- Preterm Premature Rupture of Membrane
- Nifedipine
- Placebo of Nifedipine
-
Paris, FranceTrousseau University Hospital
Sep 20, 2022